Executives at contract vaccine manufacturer Emergent BioSolutions covered up quality control problems that led to more than 400 million doses of coronavirus vaccines needing to be trashed, congressional investigators said in a report Tuesday.
From
To
Health officials in the state of Delaware say there is still a plentiful supply of COVID-19 vaccines.